Clindamycin Phosphate
Clindamycin Phosphate Topical Solution, USP 1%
Approved
Approval ID
ae7f006e-baba-4fb2-8329-35960eeaca89
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 9, 2024
Manufacturers
FDA
Glasshouse Pharmaceuticals Limited Canada
DUNS: 203493598
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Clindamycin Phosphate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71428-003
Application NumberANDA209846
Product Classification
M
Marketing Category
C73584
G
Generic Name
Clindamycin Phosphate
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 9, 2024
FDA Product Classification
INGREDIENTS (5)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
ISOPROPYL ALCOHOLInactive
Code: ND2M416302
Classification: IACT
CLINDAMYCINActive
Quantity: 10 mg in 1 mL
Code: 3U02EL437C
Classification: ACTIB